PTUPB improves cognitive function in Alzheimer’s disease associated with enhancing cerebral vascular myogenic response and attenuating vascular remodeling | Synapse
March 3, 2026
PTUPB improves cognitive function in Alzheimer’s disease associated with enhancing cerebral vascular myogenic response and attenuating vascular remodeling
Key Points
Cognitive function improved significantly in Alzheimer's disease patients after PTUPB treatment.
Cerebral vascular myogenic response was enhanced, contributing to better cognitive outcomes.
Assessment using neuropsychological tests demonstrated clear cognitive improvements pre- and post-intervention.
Highlights the potential of PTUPB as a therapeutic option in managing Alzheimer's disease.